A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment
- PMID: 21546901
- DOI: 10.1038/leu.2011.88
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment
Abstract
Several chemokines/chemokine receptors such as CCR7, CXCR4 and CXCR5 attract chronic lymphocytic leukemia (CLL) cells to specific microenvironments. Here we have investigated whether the CX(3)CR1/CX(3)CL1 axis is involved in the interaction of CLL with their microenvironment. CLL cells from 52 patients expressed surface CX(3)CR1 and CX(3)CL1 and released constitutively soluble CX(3)CL1. One third of these were attracted in vitro by soluble CX(3)CL1. CX(3)CL1-induced phosphorylation of PI3K, Erk1/2, p38, Akt and Src was involved in induction of CLL chemotaxis. Leukemic B cells upregulated CXCR4 upon incubation with CX(3)CL1 and this was paralleled by increased chemotaxis to CXCL12. Akt phosphorylation was involved in CX(3)CL1-induced upregulation of CXCR4 on CLL. In proliferation centers from CLL lymph node and bone marrow, CX(3)CL1 was expressed by CLL cells whereas CX(3)CR1 was detected in CLL and stromal cells. Nurselike cells (NLCs) generated from CLL patient blood co-expressed surface CX(3)CR1 and CX(3)CL1, but did not secrete soluble CX(3)CL1. Only half of NLC cell fractions were attracted in vitro by CX(3)CL1. In conclusion, the CX(3)CR1/CX(3)CL1 system may contribute to interactions between CLL cells and tumor microenvironment by increasing CXCL12-mediated attraction of leukemic cells to NLC and promoting directly adhesion of CLL cells to NLC.
Similar articles
-
CX3CL1/fractalkine is a novel regulator of normal and malignant human B cell function.J Leukoc Biol. 2012 Jul;92(1):51-8. doi: 10.1189/jlb.0112035. Epub 2012 Mar 27. J Leukoc Biol. 2012. PMID: 22457367 Review.
-
CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes.PLoS One. 2009 Dec 29;4(12):e8485. doi: 10.1371/journal.pone.0008485. PLoS One. 2009. PMID: 20041188 Free PMC article.
-
Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.Exp Hematol. 2010 Sep;38(9):756-64, 764.e1-4. doi: 10.1016/j.exphem.2010.05.003. Epub 2010 May 19. Exp Hematol. 2010. PMID: 20488224
-
Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.Mayo Clin Proc. 2004 Mar;79(3):318-25. doi: 10.4065/79.3.318. Mayo Clin Proc. 2004. PMID: 15008605
-
Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells.Leuk Lymphoma. 2002 Mar;43(3):461-6. doi: 10.1080/10428190290011921. Leuk Lymphoma. 2002. PMID: 12002747 Review.
Cited by
-
Fractalkine in Health and Disease.Int J Mol Sci. 2024 Jul 23;25(15):8007. doi: 10.3390/ijms25158007. Int J Mol Sci. 2024. PMID: 39125578 Free PMC article. Review.
-
Tailoring of chronic lymphatic leukemia therapy.Am J Blood Res. 2013 Aug 19;3(3):201-9. eCollection 2013. Am J Blood Res. 2013. PMID: 23997983 Free PMC article.
-
Potential role of daratumumab in the treatment of multiple myeloma.Onco Targets Ther. 2014 Jun 18;7:1095-100. doi: 10.2147/OTT.S49480. eCollection 2014. Onco Targets Ther. 2014. PMID: 24971019 Free PMC article. Review.
-
The role of G protein-coupled receptors in lymphoid malignancies.Cell Signal. 2017 Nov;39:95-107. doi: 10.1016/j.cellsig.2017.08.002. Epub 2017 Aug 9. Cell Signal. 2017. PMID: 28802842 Free PMC article. Review.
-
Aberrantly expressed Wnt5a in nurse-like cells drives resistance to Venetoclax in chronic lymphocytic leukemia.Cell Death Discov. 2022 Feb 24;8(1):82. doi: 10.1038/s41420-022-00884-y. Cell Death Discov. 2022. PMID: 35210425 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous